Ocugen, Inc.

OCGN·NasdaqCM·Healthcare
Compare
0.8745+0.1293 (+17.35%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market0.9150+0.0405 (+4.63%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.7452
Open0.8110
Day range0.78000.8900
52-week range0.69102.7250
Off day high−1.74%
Off 52-week high−67.91%
Volume8.75M
Avg. volume (3M)6.55M
Market cap296.55M
EPS (TTM)-0.2000
Forward P/E-3.45
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.98
Shares outstanding339.11M
Short interest31.60% of float
Earnings dateNov 4, 2026
Analyst target12.1667
Profit margin0.00%

Against its peers

Compare in full ›
OCGN IRD RGNX SIGHT.PA LCTX MGTX
Market cap 296.55M 355.25M 508.96M 17.22M 260.49M 904.72M
P/E (TTM) — — — — — 10.8
Forward P/E -3.5 -6.0 -2.6 -0.1 -7.5 -6.2
Price/book -16.8 -27.2 5.8 -0.5 4.3 4.1
Dividend yield — — — — — —
1-year change −36.59% +110.34% −30.98% −48.74% −40.46% +12.01%
Today +17.35% +8.65% +1.05% +1.45% +1.98% −1.05%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Ocugen's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Opus Genetics, Inc.IRD · Biotechnology 355.25M 4.2700 +8.65%
REGENXBIO Inc.RGNX · Biotechnology 508.96M 7.71 +1.05%
GenSight Biologics S.A.SIGHT.PA · Biotechnology 17.22M 0.0702 +1.45%
Lineage Cell Therapeutics, Inc.LCTX · Biotechnology 260.49M 1.0300 +1.98%
MeiraGTx Holdings plcMGTX · Biotechnology 904.72M 9.42 −1.05%
Oculis Holding AGOCS · Biotechnology 448.36M 7.28 −4.59%
Stoke Therapeutics, Inc.STOK · Biotechnology 1.78B 27.45 +1.70%
4D Molecular Therapeutics, Inc.FDMT · Biotechnology 678.40M 12.28 +2.76%

Also based in Malvern, Pennsylvania, then elsewhere in Pennsylvania.

Company Mkt cap Price Today
CubeSmartCUBE · Malvern, PA 10.39B 45.89 +3.68%
Vishay Intertechnology, Inc.VSH · Malvern, PA 3.96B 25.84 −5.07%
Vishay Precision Group, Inc.VPG · Malvern, PA 656.67M 49.37 −8.98%
Meridian CorporationMRBK · Malvern, PA 204.36M 17.12 −1.78%
Neuronetics, Inc.STIM · Malvern, PA 206.11M 2.7050 +19.69%
Annovis Bio, Inc.ANVS · Malvern, PA 51.64M 1.2100 +11.01%
TELA Bio, Inc.TELA · Malvern, PA 37.82M 0.8378 +4.46%
Comcast CorporationCMCSA · Philadelphia, PA 88.24B 24.85 +4.99%

The stocks whose daily moves over the past year went most closely with Ocugen's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
4D Molecular Therapeutics, Inc.FDMT · Correlation 0.40 678.40M 12.28 +2.76%
Lineage Cell Therapeutics, Inc.LCTX · Correlation 0.34 260.49M 1.0300 +1.98%
MeiraGTx Holdings plcMGTX · Correlation 0.32 904.72M 9.42 −1.05%
AC Immune SAACIU · Correlation 0.31 227.69M 2.2900 +9.57%

What visitors to Ocugen's page also look at.

Company Mkt cap Price Today
Bionano Genomics, Inc.BNGO 16.63M 1.1900 −0.83%
SNDL Inc.SNDL 345.14M 1.4100 +4.44%
Vaxart, Inc.VXRT 97.48M 0.4000 0.00%
Senseonics Holdings, Inc.SENS 476.92M 9.02 +1.81%
Jaguar Health, Inc.JAGX 1.16M 0.4988 −10.53%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All OCGN news ›
MyChesCo·Positive

Ocugen Targets Investors as Gene Therapy Programs Advance

MALVERN, PA — Ocugen Inc. (Nasdaq: OCGN) will present its experimental gene therapy platform at two healthcare industry conferences in November, seeking to increase investor and industry exposure for its approach to treating inherited…

OCGN
Markets Daily·Negative

Oculis (OCS) Expected to Post Earnings on Tuesday

Posted by Sarita Garza on Oct 27th, 2026 Read Our Latest Stock Report on OCS Oculis is a global biopharmaceutical company focused on developing innovative treatments for eye diseases. The company’s research is centered on therapies that…

OCSOCGNOCUL
healio.com·Negative

OCU410 gene therapy shows potential in geographic atrophy

Take Homes in Retina OCU410 gene therapy shows potential in geographic atrophy NEW ORLEANS — In this video, Jennifer I. Lim, MD, discusses phase 2 data on OCU410 presented at the American Academy of Ophthalmology meeting. The trial…

OCGN
Channel Eye·Positive

Ocorian appoints Global Head of Issuer Services

Ocorian has appointed Kristina Rowe to the new role of Global Head of Issuer Services, based in London. Kristina (pictured) joined Ocorian in 2019 and has Ocorian has appointed Kristina Rowe to the new role of Global Head of Issuer…

OGSOCGNOCSPFE

From the 4Search news index, newest first.

In the news

32mentions in 30 days
25with it in the headline
Positivesentiment

Mentioned with

Ocugen, Inc.27Oculis Holding AG11Pfizer8Board of Directors7LinkedIn7U.S. Food and Drug Administration7Merrill Lynch6Stargardt6

People in the coverage

Ocugen26Shankar Musunuri26Stargardt17Jolanda Crombach13Oculis9Michael Walen8

Themes

Healthcare22Biotechnology21SEC Filings19Including RP8Stargardt Disease8And Ga.7Gene Therapy7Biotech6

Most coverage from

  1. stocktitan.net9
  2. globenewswire.com3
  3. manilatimes.net2
  4. quiverquant.com2
  5. themarketsdaily.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 32 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance